- Location
Sustained Release Drug
"-
SMC Has Accepted ILUVIEN for Use Within The NHS
Feb 25, 2014pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the Scottish Medicines Consortium (SMC) has accepted ILUVIEN® for use ...
-
BioTime Has Entered Into a Sublicense Agreement with Jade Therapeutics
Sep 20, 2013US-based biotechnology firm BioTime has entered into a sublicense agreement with Jade Therapeutics, a developer of ophthalmic sustained-release drug delivery platforms, for ophthalmic drug delivery applications of BioTime's HyStem ...
Tags: Health, Medicine, biotechnology
-
Drug Delivery Company to Develop and Market a Sustained-Release Drug Delivery Platform
Feb 28, 2013Rainbow BioSciences' biotech division Rainbow Coral (RBCC) has revealed that it is currently working on a potential joint venture agreement with a privately held drug delivery company to develop and market a sustained-release drug delivery ...
Tags: RBCC, Sustained-Release Drug, Medicine
-
For Its Drug Delivery Platform,Atlantic Pharmaceuticals Has Received Two New USPTO Patents
Dec 25, 2012Atlantic Pharmaceuticals has received two new US Patent and Trademark Office (USPTO) patents for its tamper-resistant SMART/Script drug delivery platform. The patents cover company's tamper-resistant platforms, designed to resist dose ...
Tags: Atlantic Pharmaceuticals, US Patent, drug delivery platform, healthcare
-
pSivida Enters Into an Agreement with a Biopharmaceutical Company
Dec 17, 2012pSivida, a developer of sustained release drug delivery products, has entered into an agreement with a biopharmaceutical company for the evaluation of its Tethadur protein/antibody delivery technology. Designed for use in the field of ...
